Efficient data management for enhanced research productivity
Fueling innovation productivity is a key to success in R&D. Intensive environments and effective data management is paramount in this age of collaboration.
Arxspan’s cloud-based ArxLab® ELN, ArxLab® Registration, ArxLab® Inventory and ArxLab® Assay system is a research-centric knowledge management platform that can help an organization realize the value of its data during this age of information explosion by ensuring quality, consistency and secure access. Its straight-forward turn-key web-browser solution eliminates IT pain for start-up Biotechs have suffered in the past.
Benefits For Biotechnology
An organization’s most valuable asset is the IP from its research, be it internal or out-sourced. Data standards, security and compliance with 21 CFR Part 11 are included in the software.
Low cost data migration from legacy systems is performed by the Arxspan team of professionals.
Secure uniform data storage eliminates problems caused by data locked away in disparate data sources including personal drives, paper lab notebooks, networks and data warehouses. Organizations can now realize the cumulative benefit gained over the research life cycle with instant searchable access, analysis and insight to IP.
ArxLab® ELN is 21 CFR Part 11 compliant and offers optional SAFE-BioPharma support.
ArxLab’s® easy-to-use interface works the way scientists work and reduces time consuming manual processes and streamlines workflow and information exchange.
Cloud-based deployment lowers the set up costs to organizations as well as reduces IT support and maintenance costs.
Deployment of the Arxspan software is flexible with cloud-based or on-premise options. The web based user environment is accessible from any device or operating system. Arxspan’s ArxLab® Notebook, Registration, and Inventory can be purchased as a suite or as stand alone modules.
Avoids Data Silos
Eliminate the data silos and manual processes in your organization and seek a faster, more cost effective way to capitalize R&D spend.